Article(id=1329905811100381604, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905755949478607, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2025.08.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1748880000000, receivedDateStr=2025-06-03, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795003853820, onlineDateStr=2026-11-18, pubDate=1754755200000, pubDateStr=2025-08-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795003853820, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795003853820, creator=13701087609, updateTime=1795003853820, updator=13701087609, issue=Issue{id=1329905755949478607, tenantId=1146029695717560320, journalId=1319690259887390882, year='2025', volume='56', issue='8', pageStart='975', pageEnd='1108', issueExtLink='null', onlineDate='null', pubDate='1754755200000', pubDateStr='2025-08-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1795003840672, creator='13701087609', updateTime=1795004363274, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329907948366705176, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905755949478607, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329907948366705177, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329905755949478607, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=975, endPage=983, ext={EN=ArticleExt(id=1329905811331068325, articleId=1329905811100381604, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Nanoparticle Drug Delivery Systems for the Treatment of Metabolic Associated Fatty Liver Disease, columnId=1325194059773522066, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Perspectives & Review, runingTitle=null, highlight=null, articleAbstract=
Metabolic associated fatty liver disease(MAFLD) is a liver disease characterized by hepatic steatosis,accompanied by metabolic abnormality. In recent years, the incidence of MAFLD has significantly increased due to lifestyle changes and rising obesity rates, becoming an important public health challenge globally. Despite advancements in mechanistic understanding and escalating research efforts on therapeutic agents, effective pharmacological interventions for MAFLD remain limited. Notably, the development of potential therapeutics is often hindered by critical drawbacks such as poor stability, low bioavailability, and inadequate hepatic targeting. Nanoparticle drug delivery systems offer a promising solution by enhancing drug stability, improving solubility and bioavailability, and enabling precise hepatic targeting. This review primarily introduces the pathogenesis, diagnostic criteria, current treatment status, and challenges in drug development for MAFLD, with a particular focus on the application of nanoparticle drug delivery systems to MAFLD treatment, aiming to provide references for the development of therapeutic drugs for MAFLD.
, authors=Qinghui FU, Jie LIU, Jun HE
*, authorsList=Qinghui FU, Jie LIU, Jun HE, authorCompany=null, correspAuthors=Jun HE, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329905811725332902, articleId=1329905811100381604, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=纳米给药系统在代谢相关脂肪性肝病治疗中的应用, columnId=1322624444544176331, journalTitle=中国医药工业杂志, columnName=专论与综述, runingTitle=null, highlight=null, articleAbstract=
代谢相关脂肪性肝病(MAFLD)是一种以肝脏脂肪变性为核心特征,并伴有代谢异常的肝脏疾病。近年来,随着生活方式的改变和肥胖率的上升,MAFLD的发病率显著上升,已成为全球公共健康的重要挑战之一。尽管人们对MAFLD的认识不断加深,相关药物的研究也在逐年增加,但目前针对该病的治疗药物仍相对有限。值得注意的是,一些潜在药物因稳定性差、生物利用度低、肝靶向性弱等问题,导致临床应用受限。而纳米给药系统凭借其可增强药物稳定性、提高溶解度和生物利用度、增强肝脏靶向性等优势,为该类药品的开发提供了解决方案。该文主要综述了MAFLD的发病机制、诊断标准、治疗现状及药物研发困境,并重点探讨了纳米给药系统在MAFLD治疗中的应用,以期为MAFLD治疗药物的开发提供参考。
, authors=付庆辉, 刘洁, 何军
*, authorsList=付庆辉, 刘洁, 何军, authorCompany=null, correspAuthors=何军, authorNote=
, correspAuthorsNote=
何军,研究员,博士生导师,从事新型给药系统的研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=siQEUGWvqL2kU/fvBzQDgg==, magXml=x844YjWYmng4kvxjm3gPwg==, pdfUrl=null, pdf=t5QK434mWD+MErqpOyjZGQ==, pdfFileSize=1111138, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=SLuLMUC8drREF5SIvievow==, mapNumber=null, fund=null)}, authors=[Author(id=1329905812098625963, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905812216066477, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, authorId=1329905812098625963, language=EN, stringName=Qinghui FU, firstName=Qinghui, middleName=null, lastName=FU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905812283175342, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, authorId=1329905812098625963, language=CN, stringName=付庆辉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio={"content":"
付庆辉,硕士研究生,专业方向:新型给药系统。
"}, bioImg=null, bioContent=
付庆辉,硕士研究生,专业方向:新型给药系统。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905811997962663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, xref=null, ext=[AuthorCompanyExt(id=1329905812010545576, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, companyId=1329905811997962663, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905812023128489, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, companyId=1329905811997962663, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1329905812367061424, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329905812463530418, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, authorId=1329905812367061424, language=EN, stringName=Jie LIU, firstName=Jie, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905812534833587, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, authorId=1329905812367061424, language=CN, stringName=刘洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905811997962663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, xref=null, ext=[AuthorCompanyExt(id=1329905812010545576, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, companyId=1329905811997962663, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905812023128489, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, companyId=1329905811997962663, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])]), Author(id=1329905812610331061, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329905812685828535, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, authorId=1329905812610331061, language=EN, stringName=Jun HE, firstName=Jun, middleName=null, lastName=HE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329905812765520312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, authorId=1329905812610331061, language=CN, stringName=何军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329905811997962663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, xref=null, ext=[AuthorCompanyExt(id=1329905812010545576, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, companyId=1329905811997962663, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905812023128489, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, companyId=1329905811997962663, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])])], keywords=[Keyword(id=1329905812866183609, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, language=EN, orderNo=1, keyword=metabolic associated fatty liver disease), Keyword(id=1329905812924903866, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, language=EN, orderNo=2, keyword=fatty liver disease), Keyword(id=1329905813033955771, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, language=EN, orderNo=3, keyword=nanoparticle drug delivery system), Keyword(id=1329905813105258940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, language=EN, orderNo=4, keyword=nanoparticle), Keyword(id=1329905813176562109, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, language=EN, orderNo=5, keyword=nauoemulsion), Keyword(id=1329905813239476670, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, language=CN, orderNo=1, keyword=代谢相关脂肪性肝病), Keyword(id=1329905813302391231, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, language=CN, orderNo=2, keyword=脂肪性肝病), Keyword(id=1329905813365305792, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, language=CN, orderNo=3, keyword=纳米给药系统), Keyword(id=1329905813432414657, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, language=CN, orderNo=4, keyword=纳米粒), Keyword(id=1329905813499523522, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, language=CN, orderNo=5, keyword=纳米乳)], refs=[Reference(id=1329905813797319109, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=LE M H, YEO Y H, LI X,
et al.2019 Global NAFLD prevalence: a systematic review and meta-analysis [J].
Clin Gastroenterol Hepatol, 2022,
20(12): 2809-17. e28., articleTitle=null, refAbstract=null), Reference(id=1329905813881205190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ESLAM M, NEWSOME P N, SARIN S K,
et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement [J].
J Hepatology, 2020,
73(1): 202-209., articleTitle=null, refAbstract=null), Reference(id=1329905813948314055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=KHADAM V K R, SINGH R P, PRAJAPATI D,
et al.An updated comprehensive review on novel drug delivery systems(NDDS) in the pharmaceuticals [J].
Asian J Pharm Res Dev, 2024,
12(1): 55-64., articleTitle=null, refAbstract=null), Reference(id=1329905814028005832, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=DAY C P, JAMES O F.Steatohepatitis: a tale of two “hits”?[J].
Gastroenterology, 1998,
114(4): 842-845., articleTitle=null, refAbstract=null), Reference(id=1329905814103503305, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=DAY C P, SAKSENA S.Non-alcoholic steatohepatitis:definitions and pathogenesis [J].
J Gastroenterol Hepatol,2002,
17 Suppl 3: S377-S384., articleTitle=null, refAbstract=null), Reference(id=1329905814179000778, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=XIE Z F, LI Y F, CHENG L,
et al.Potential therapeutic strategies for MASH: from preclinical to clinical development[J].
Life Metab, 2024,
3(5): loae029., articleTitle=null, refAbstract=null), Reference(id=1329905814258692555, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=FRIEDMAN S L, NEUSCHWANDER-TETRI B A,RINELLA M,
et al.Mechanisms of NAFLD development and therapeutic strategies [J].
Nat Med, 2018,
24(7): 908-922., articleTitle=null, refAbstract=null), Reference(id=1329905814346772940, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=LOMONACO R, ORTIZ-LOPEZ C, ORSAK B,
et al.Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease [J].
Hepatology, 2012,
55(5): 1389-1397., articleTitle=null, refAbstract=null), Reference(id=1329905814422270413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=ARROYAVE-OSPINA J C, WU Z M, GENG Y N,
et al.Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy [J].
Antioxidants (Basel), 2021,
10(2): 174., articleTitle=null, refAbstract=null), Reference(id=1329905814510350798, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=BARREBY E, CHEN P, AOUADI M.Macrophage functional diversity in NAFLD - more than inflammation [J].
Nat Rev Endocrinol, 2022,
18(8): 461-472., articleTitle=null, refAbstract=null), Reference(id=1329905814569071055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=BIANCO C, ROMEO S, PETTA S,
et al. MAFLD vs NAFLD:let the contest begin! [J].
Liver International, 2020,
40(9):2079-2081., articleTitle=null, refAbstract=null), Reference(id=1329905814627791312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=YAMAMURA S, ESLAM M, KAWAGUCHI T,
et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD [J].
Liver International, 2020,
40(12): 3018-3030., articleTitle=null, refAbstract=null), Reference(id=1329905814699094481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=VILAR-GOMEZ E, MARTINEZ-PEREZ Y, CALZADILLA-BERTOT L,
et al.Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis [J].
Gastroenterology, 2015,
149(2): 367-78.e5., articleTitle=null, refAbstract=null), Reference(id=1329905814770397650, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=SAWAMOTO R, NOZAKI T, NISHIHARA T,
et al.Predictors of successful long-term weight loss maintenance: a two-year follow-up [J].
Biopsychosoc Med, 2017,
11: 14., articleTitle=null, refAbstract=null), Reference(id=1329905814837506515, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=HARRISON S A, TAUB R, NEFF G W,
et al.Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial [J].
Nat Med, 2023,
29(11): 2919-2928., articleTitle=null, refAbstract=null), Reference(id=1329905814900421076, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=ANASTASIOU G, STEFANAKIS K, HILL M A,
et al.Expanding diagnostic and therapeutic horizons for MASH:comparison of the latest and conventional therapeutic approaches [J].
Metabolism, 2024,
161: 156044., articleTitle=null, refAbstract=null), Reference(id=1329905814967529941, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=ITO D, SHIMIZU S, HAISA A,
et al.Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: effect of ipragliflozin in MASLD [J].
J Diabetes Investig, 2024,
15(9): 1220-1230., articleTitle=null, refAbstract=null), Reference(id=1329905815030444502, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO Y, ZHAO W L, BU H E,
et al.Liraglutide on type 2 diabetes mellitus with nonalcoholic fatty liver disease:a systematic review and meta-analysis of 16 RCTs [J].
Medicine (Baltimore), 2023,
102(6): e32892., articleTitle=null, refAbstract=null), Reference(id=1329905815097553367, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=ARAI T, ATSUKAWA M, TSUBOTA A,
et al.Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease: a prospective, multicentre, observational study [J].
Diabetes Obes Metab, 2024,
26(11): 4958-4965., articleTitle=null, refAbstract=null), Reference(id=1329905815168856536, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=ESPINOSA M A, FANSA S, ANAZCO D,
et al.S2120 Tirzepatide and MASLD: real-world outcomes in patients with overweight and obesity [J].
Am J Gastroenterol, 2024,
119(10S): S1513-S1514., articleTitle=null, refAbstract=null), Reference(id=1329905815240159705, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=SANYAL A J, KAPLAN L M, FRIAS J P,
et al.Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial [J].
Nat Med, 2024,
30(7): 2037-2048., articleTitle=null, refAbstract=null), Reference(id=1329905815298879962, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=KAWAGUCHI T, FUJISHIMA Y, WAKASUGI D,
et al.Effects of SGLT2 inhibitors on the onset of esophageal varices and extrahepatic cancer in type 2 diabetic patients with suspected MASLD: a nationwide database study in Japan [J].
J Gastroenterol, 2024,
59(12): 1120-1132., articleTitle=null, refAbstract=null), Reference(id=1329905815374377435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=DO A, ILAGAN-YING Y C, MEHAL W Z,
et al.Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints [J].
Expert Opin Drug Discov, 2021,
16(2): 125-134., articleTitle=null, refAbstract=null), Reference(id=1329905815449874908, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=CHALASANI N, YOUNOSSI Z, LAVINE J E,
et al.The diagnosis and management of nonalcoholic fatty liver disease:practice guidance from the American Association for the Study of Liver Diseases [J].
Hepatology, 2018,
67(1): 328-357., articleTitle=null, refAbstract=null), Reference(id=1329905815508595165, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG K, ZHANG Y, WANG G J,
et al.FXR agonists for MASH therapy: lessons and perspectives from obeticholic acid[J].
Med Res Rev, 2024,
44(2): 568-586., articleTitle=null, refAbstract=null), Reference(id=1329905815567315422, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU J, YUAN Y L, GONG X,
et al.Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice [J].
Int Immunopharmacol, 2020,
80: 106208., articleTitle=null, refAbstract=null), Reference(id=1329905815634424287, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=YAN B F, ZHENG X, WANG Y,
et al.Liposome-based silibinin for mitigating nonalcoholic fatty liver disease:dual effects via parenteral and intestinal routes [J].
ACS Pharmacol Transl Sci, 2023,
6(12): 1909-1923., articleTitle=null, refAbstract=null), Reference(id=1329905815714116064, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU H, JIANG N M, KUANG G,
et al.Chrysin and its nanoliposome ameliorated non-alcoholic steatohepatitis via inhibiting TLR4 signalling pathway [J].
J Pharm Pharmacol,2023,
75(8): 1046-1057., articleTitle=null, refAbstract=null), Reference(id=1329905815793807841, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=SALEM G A, MOHAMED A A, KHATER S I,
et al.Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: involvement of SMO, GLI-1,and PTCH-1 genes [J].
Gene, 2023,
883: 147670., articleTitle=null, refAbstract=null), Reference(id=1329905815869305314, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=YU Y, WANG Q, HUANG X,
et al.GA receptor targeted chitosan oligosaccharide polymer nanoparticles improve non-alcoholic fatty liver disease by inhibiting ferroptosis [J].
Int J Biol Macromol, 2024,
278(Pt 2): 134779., articleTitle=null, refAbstract=null), Reference(id=1329905815940608483, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO R F, ZHU M L, ZHOU S,
et al.Rapamycin-loaded mPEG-PLGA nanoparticles ameliorate hepatic steatosis and liver injury in non-alcoholic fatty liver disease [J].
Front Chem, 2020,
8: 407., articleTitle=null, refAbstract=null), Reference(id=1329905816007717348, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=WAN S Q, ZHANG L, QUAN Y Y,
et al.Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy [J].
R Soc Open Sci, 2018,
5(11): 181457., articleTitle=null, refAbstract=null), Reference(id=1329905816070631909, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=LIANG J, LIU Y, LIU J G,
et al.Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD [J].
J Nanobiotechnology, 2018,
16(1): 64., articleTitle=null, refAbstract=null), Reference(id=1329905816137740774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=ABDOU E M, FAYED M A A, HELAL D,
et al.Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles(LPHNPs) encapsulating naturally extracted β-Sitosterol against CCl4 induced hepatotoxicity in rats [J].
Sci rRep, 2019,
9(1): 19779., articleTitle=null, refAbstract=null), Reference(id=1329905816196461031, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=FAROOQ A, IQBAL A, RANA N F,
et al.A novel Sprague-Dawley rat model presents improved NASH/NAFLD symptoms with PEG coated vitexin liposomes [J].
Int J Mol Sci, 2022,
23(6): 3131., articleTitle=null, refAbstract=null), Reference(id=1329905816255181288, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=LYU Y F, YANG X Y, YANG L,
et al.Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease [J].
J Control Release, 2024,
373: 385-398., articleTitle=null, refAbstract=null), Reference(id=1329905816322290153, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=BAI Y, NAN Y Y, WU T,
et al.Lipid nanoparticle-mediated delivery of CRISPR-Cas9 against rubicon ameliorates NAFLD by modulating CD36 along with glycerophospholipid metabolism [J].
Adv Sci (Weinh), 2024,
11(31): e2400493., articleTitle=null, refAbstract=null), Reference(id=1329905816397787626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=LOPEZ-PASCUAL A, RUSSO-CABRERA J S, ARDAIZ N,
et al.Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD) [J].
Clin Sci, 2024,
138(20): 1265-1284., articleTitle=null, refAbstract=null), Reference(id=1329905816460702187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=ELBASET M A, NASR M, IBRAHIM B M,
et al.Curcumin nanoemulsion counteracts hepatic and cardiac complications associated with high‐fat/high‐fructose diet in rats [J].
J Food Biochem, 2022,
46(12): e14442., articleTitle=null, refAbstract=null), Reference(id=1329905816527811052, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=ZAMORA-LÓPEZ K, NORIEGA L G, ESTANES-HERNÁNDEZ A,
et al.
Punica granatum L.-derived omega-5 nanoemulsion improves hepatic steatosis in mice fed a high fat diet by increasing fatty acid utilization in hepatocytes [J].
Sci Rep, 2020,
10(1): 15229., articleTitle=null, refAbstract=null), Reference(id=1329905816590725613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=EL-SHERBINY M, ELDOSOKY M, EL-SHAFEY M,
et al.Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet [J].
Chem Biol Interact, 2018,
288: 65-75., articleTitle=null, refAbstract=null), Reference(id=1329905816657834478, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=ELIADES M, SPYROU E.Vitamin D: a new player in non-alcoholic fatty liver disease? [J].
World J Gastroenterol,2015,
21(6): 1718-1727., articleTitle=null, refAbstract=null), Reference(id=1329905816729137647, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=VARGAS-MENDOZA N, MADRIGAL-SANTILLÁN E,MORALES-GONZÁLEZ A,
et al.Hepatoprotective effect of silymarin [J].
World J Hepatol, 2014,
6(3): 144-149., articleTitle=null, refAbstract=null), Reference(id=1329905816796246512, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=KESHARWANI S S, JAIN V, DEY S,
et al.An overview of advanced formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of silymarin[J].
J Drug Delivery Sci Technol, 2020,
60: 102021., articleTitle=null, refAbstract=null), Reference(id=1329905816871743985, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN Y, JIANG Z H, XU J Z,
et al.Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice [J].
J Nanobiotechnology, 2021,
19(1): 230., articleTitle=null, refAbstract=null), Reference(id=1329905816964018674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=DINDA B, DINDA S, DASSHARMA S,
et al.Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders [J].
Eur J Med Chem, 2017,
131: 68-80., articleTitle=null, refAbstract=null), Reference(id=1329905817039516147, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=INAMDAR S, JOSHI A, MALIK S,
et al.Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice [J].
Biochem Biophys Res Commun, 2019,
519(1): 106-112., articleTitle=null, refAbstract=null), Reference(id=1329905817115013620, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG Y, SHI M, FU H,
et al. Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease [J].
Mol Med Rep, 2010,
3(6): 909-915., articleTitle=null, refAbstract=null), Reference(id=1329905817186316789, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=OTHMAN R, VLADISAVLJEVIC G T, NAGY Z K,
et al.Encapsulation and controlled release of rapamycin from polycaprolactone nanoparticles prepared by membrane micromixing combined with antisolvent precipitation [J].
Langmuir, 2016,
32(41): 10685-10693., articleTitle=null, refAbstract=null), Reference(id=1329905817257619958, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=NAKAGAMI H, SHIMAMURA M, MIYAKE T,
et al.Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet [J].
Mol Med Rep, 2012,
5(1): 37-40., articleTitle=null, refAbstract=null), Reference(id=1329905817324728823, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE S, HAN D, KANG H G,
et al. Intravenous sustained-release nifedipine ameliorates nonalcoholic fatty liver disease by restoring autophagic clearance [J].
Biomaterials, 2019,
197: 1-11., articleTitle=null, refAbstract=null), Reference(id=1329905817404420600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=JOHNSON L T, ZHANG D, ZHOU K J,
et al.Lipid nanoparticle(LNP) chemistry can endow unique
in vivo RNA delivery fates within the liver that alter therapeutic outcomes in a cancer model [J].
Mol Pharm, 2022,
19(11): 3973-3986., articleTitle=null, refAbstract=null), Reference(id=1329905817492500985, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG R, EL-MAYTA R, MURDOCH T J,
et al.Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver [J].
Biomater Sci,2021,
9(4): 1449-1463., articleTitle=null, refAbstract=null), Reference(id=1329905817584775674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=GAO M H, ZHONG J F, LIU X X,
et al.Deciphering the role of PEGylation on the lipid nanoparticle-mediated mRNA delivery to the liver [J].
ACS nano, 2025,
19(6): 5966-5978., articleTitle=null, refAbstract=null), Reference(id=1329905817647690235, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=SAEED A, BARTUZI P, HEEGSMA J,
et al.Impaired hepatic vitamin A metabolism in NAFLD mice leading to vitamin A accumulation in hepatocytes [J].
Cell Mol Gastroenterol Hepatol, 2021,
11(1): 309-325.e3., articleTitle=null, refAbstract=null), Reference(id=1329905817702216188, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=SHAN X Z, ZHAO Z Q, LAI P P,
et al.RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment [J].
Nat Commun, 2024,
15(1): 7263., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329905813600186819, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, awardId=23S41900200, language=CN, fundingSource=上海市“科技创新行动计划”生物医药科技支撑专项项目(23S41900200), fundOrder=null, country=null), Fund(id=1329905813692461508, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, awardId=23J21900600, language=CN, fundingSource=上海市“科技创新行动计划”细胞与基因治疗专项项目(23J21900600), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329905811997962663, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, xref=null, ext=[AuthorCompanyExt(id=1329905812010545576, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, companyId=1329905811997962663, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Advanced Medical Engineering Research Center, China State Institute of Pharmaceutical Industry, Shanghai 201203), AuthorCompanyExt(id=1329905812023128489, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329905811100381604, companyId=1329905811997962663, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=中国医药工业研究总院医药先进制造国家工程研究中心,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2025.08.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.08.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2025.08.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2025.08.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1754755200000, fullTextJson=null, articleText=null, reference=null)